KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment

Terminated

• Conditions: Antipsychotic Treatment; Quality Assurance; Medical Treatment

• Registration Number: NCT00750776
• Lead Sponsor: Psychiatric Centre Rigshospitalet

Brief Summary

Rating and registration in KMS database of all patients in anti-psychotic treatment with 8 selected items from PANSS, GAF, 21 selected items from UKU, 3 selected items from TSQM. and measurement of compliance. Frequency of use of rating scales per participating health care professional.

Detailed Description

Not available

Study Timeline

• Study Start: 2003-08
• Study First Submitted: 2008-09-10
• Study First Submitted QC: 2008-09-10
• Study First Posted: 2008-09-11
• Study Completion: 2012-08
• Status Verified: 2013-04
• Last Update Submitted: 2013-04-14
• Last Update Posted: 2013-04-16

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 212

Inclusion Criteria

• All patients where a physician has decided to treat the patient with antipsychotics.
• All patients that are treated within the Danish health care system

Exclusion Criteria

• Patients that are treated in accordance with "Law concerning freedom deprivation and other compulsion in psychiatry
• Patients that are in judicial measure

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
GAF score >= 30 or have an improvement on >= 5 points at the GAF scale	All measures are rated every ½ year at least.GAF: At least 85 % of the rated patients must have a score >= 30 or have an improvement on >= 5 points at the GAF scale

Secondary Outcome Measures

Name	Time	Method
UKU: Share of patients that have a score <=1 on the selected 21 items from the UKU scale	UKU: At least 75 % of the patients have a score on <=1 on the selected items UKU scale.At least 30 % of the patients are examined for metabolic syndrom.
PANSS: Share af patients that have a score >= 3 on each an every of the following items P1, P2, P3, N1, N4, N6, G5, G9	PANSS: At least 70% of the patients have a score <= 3 on each an every of the following items P1, P2, P3, N1, N4, N6, G5, G9
Compliance: Share of patients have according to the specialists evaluation have taken their antipsychotic medicine according to prescription	Compliance: At least 75% of the patients have according to the specialists evaluation taken their antipsychotic medicine according to prescription
Patient satisfaction:Share of patients that scores in one of the to best categories i all selected 3 items in the TSQM scale.	Patient satisfaction:At least 65 % of the patients scores in one of the to best kategories in all the selected 3 items in the TSQM scale.

Trial Locations

Locations (2)

Research Site; 🇩🇰 Varde, Denmark

ResearcH Site; 🇩🇰 Holbaek, Denmark